Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Prostate Cancer

Free Subscription Articles published in Oncol Rep Retrieve available abstracts of 10 articles: HTML format

Single Articles

April 2025
1. GUO X, Li S
   Bone metastases of prostate cancer: Molecular mechanisms, targeted diagnosis and targeted therapy (Review).
   Oncol Rep. 2025;53:46.
   PubMed     Abstract available
   
   
   February 2025
2. YANG C, Wang L, Gong C, Lv D, et al
   Antibody?drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape (Review).
   Oncol Rep. 2025;53:21.
   PubMed     Abstract available
   
   
   November 2024
3. ZHOU Y, Ji Z, Yan W, Zhou Z, et al
   [Retracted] Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1.
   Oncol Rep. 2024;52:152.
   PubMed     Abstract available
   
   
   October 2024
4. NOURUZI S, Johnson F, Kumar S, Sivak O, et al
   Targeting adenocarcinoma and enzalutamide?resistant prostate cancer using the novel anti?androgen inhibitor ADA?308.
   Oncol Rep. 2024;52:132.
   PubMed     Abstract available
   
   
   June 2024
5. LIU Y, Qin Z, Yang K, Liu R, et al
   [Corrigendum] Cripto?1 promotes epithelial?mesenchymal transition in prostate cancer via Wnt/beta?catenin signaling.
   Oncol Rep. 2024;51:75.
   PubMed     Abstract available
   
   
   
6. PAN J, Tong F, Ren N, Ren L, et al
   Role of N(6)?methyladenosine in the pathogenesis, diagnosis and treatment of prostate cancer (Review).
   Oncol Rep. 2024;51:88.
   PubMed     Abstract available
   
   
   May 2024
7. HSIA YJ, Lin ZM, Zhang T, Chou TC, et al
   Butyrate increases methylglyoxal production through regulation of the JAK2/Stat3/Nrf2/Glo1 pathway in castration?resistant prostate cancer cells.
   Oncol Rep. 2024;51:71.
   PubMed     Abstract available
   
   
   March 2024
8. PARAJULI KR, Jung Y, Taichman RS
   Abscisic acid signaling through LANCL2 and PPARgamma induces activation of p38MAPK resulting in dormancy of prostate cancer metastatic cells.
   Oncol Rep. 2024;51:39.
   PubMed     Abstract available
   
   
   January 2024
9. LEE DY, Chun JN, So I, Jeon JH, et al
   Oncogenic role of FOXM1 in human prostate cancer (Review).
   Oncol Rep. 2024;51:15.
   PubMed     Abstract available
   
   
   December 2023
10. LEE DY, Lee S, Kim YS, Park S, et al
    Cyclosporin A inhibits prostate cancer growth through suppression of E2F8 transcription factor in a MELK?dependent manner.
    Oncol Rep. 2023;50:218.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.